Vifor Confident About Veltassa Despite AZ Rival

Hyperkalemia Therapy Now Has Competition From Lokelma

 
• By Kevin Grogan
  
Two_Road_Bikers
Vifor looks to maintain its lead over AstraZeneca in hyperkalemia market • Source: Shutterstock

More from Blood and Clotting

More from Therapy Areas